C0033684||protein
C0243077||inhibitor
C3658228||site 3 of Ca(2+)-bound S100B
C0206755||X-ray crystallography
C0920472||Structure-based drug discovery
C1328819||small-molecule
C3658228||S100B
C0243077||inhibitors
C0243077||SBiXs
C0243077||inhibitors
C0025202||malignant melanoma
C3658228||S100B
C0013081||downregulate
C0080055||wild-type p53
C1325410||tumor suppressor function
C0025202||cancer
C0206755||X-ray crystallographic studies
C3658228||S100B
C0243077||SBiX
C1704241||complexes
C0237406||apomorphine hydrochloride
C0019873||ethidium bromide
C3658228||S100B
C0205242||cleft
C0205675||site 3
C0033684||protein
C0243077||inhibitor
C0184511||improve
C0243077||SBiX
C0237406||apomorphine hydrochloride
C3658228||S100B
C0599733||killing
C1513095||melanoma cell
C1510438||assays
C3658228||S100B
C0205675||site 3
C2603343||studies
C3658228||S100B
C0205675||site 3
C3658228||S100B